nodes	percent_of_prediction	percent_of_DWPC	metapath
Fesoterodine—CHRM3—epilepsy syndrome	0.147	0.304	CbGaD
Fesoterodine—CHRM1—epilepsy syndrome	0.137	0.283	CbGaD
Fesoterodine—CHRM2—epilepsy syndrome	0.112	0.231	CbGaD
Fesoterodine—CYP2D6—epilepsy syndrome	0.0512	0.106	CbGaD
Fesoterodine—ABCB1—epilepsy syndrome	0.0366	0.0756	CbGaD
Fesoterodine—ABCB1—Levetiracetam—epilepsy syndrome	0.0248	0.0871	CbGbCtD
Fesoterodine—ABCB1—Clobazam—epilepsy syndrome	0.0172	0.0603	CbGbCtD
Fesoterodine—ABCB1—Lamotrigine—epilepsy syndrome	0.0166	0.0581	CbGbCtD
Fesoterodine—ABCB1—Carbamazepine—epilepsy syndrome	0.0143	0.05	CbGbCtD
Fesoterodine—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0136	0.0477	CbGbCtD
Fesoterodine—ABCB1—Phenytoin—epilepsy syndrome	0.0128	0.0448	CbGbCtD
Fesoterodine—CYP3A4—Felbamate—epilepsy syndrome	0.0126	0.0443	CbGbCtD
Fesoterodine—CYP3A4—Trimethadione—epilepsy syndrome	0.0126	0.0443	CbGbCtD
Fesoterodine—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0119	0.0417	CbGbCtD
Fesoterodine—ABCB1—Phenobarbital—epilepsy syndrome	0.0114	0.04	CbGbCtD
Fesoterodine—ABCB1—Midazolam—epilepsy syndrome	0.0112	0.0394	CbGbCtD
Fesoterodine—CYP2D6—Propofol—epilepsy syndrome	0.0112	0.0394	CbGbCtD
Fesoterodine—ABCB1—Diazepam—epilepsy syndrome	0.0108	0.0379	CbGbCtD
Fesoterodine—CYP3A4—Clonazepam—epilepsy syndrome	0.0108	0.0377	CbGbCtD
Fesoterodine—CYP3A4—Clobazam—epilepsy syndrome	0.0103	0.0362	CbGbCtD
Fesoterodine—CYP3A4—Rufinamide—epilepsy syndrome	0.00877	0.0307	CbGbCtD
Fesoterodine—CYP3A4—Carbamazepine—epilepsy syndrome	0.00854	0.03	CbGbCtD
Fesoterodine—CYP3A4—Primidone—epilepsy syndrome	0.00798	0.028	CbGbCtD
Fesoterodine—CYP3A4—Phenytoin—epilepsy syndrome	0.00766	0.0269	CbGbCtD
Fesoterodine—CYP3A4—Propofol—epilepsy syndrome	0.00715	0.0251	CbGbCtD
Fesoterodine—CYP3A4—Phenobarbital—epilepsy syndrome	0.00683	0.0239	CbGbCtD
Fesoterodine—CYP3A4—Acetazolamide—epilepsy syndrome	0.00683	0.0239	CbGbCtD
Fesoterodine—CYP3A4—Midazolam—epilepsy syndrome	0.00673	0.0236	CbGbCtD
Fesoterodine—CYP3A4—Diazepam—epilepsy syndrome	0.00647	0.0227	CbGbCtD
Fesoterodine—CYP3A4—Zonisamide—epilepsy syndrome	0.00632	0.0222	CbGbCtD
Fesoterodine—CYP3A4—Valproic Acid—epilepsy syndrome	0.0051	0.0179	CbGbCtD
Fesoterodine—CYP3A4—Topiramate—epilepsy syndrome	0.0046	0.0161	CbGbCtD
Fesoterodine—Disopyramide—KCND2—epilepsy syndrome	0.00148	0.369	CrCbGaD
Fesoterodine—Disopyramide—CHRM3—epilepsy syndrome	0.000407	0.102	CrCbGaD
Fesoterodine—Tolterodine—CHRM3—epilepsy syndrome	0.000407	0.102	CrCbGaD
Fesoterodine—CHRM4—head—epilepsy syndrome	0.000396	0.0456	CbGeAlD
Fesoterodine—Tolterodine—CHRM1—epilepsy syndrome	0.000379	0.0948	CrCbGaD
Fesoterodine—Disopyramide—CHRM1—epilepsy syndrome	0.000379	0.0948	CrCbGaD
Fesoterodine—CHRM4—nervous system—epilepsy syndrome	0.000375	0.0432	CbGeAlD
Fesoterodine—CHRM2—forebrain—epilepsy syndrome	0.000371	0.0427	CbGeAlD
Fesoterodine—CHRM4—central nervous system—epilepsy syndrome	0.000361	0.0416	CbGeAlD
Fesoterodine—CHRM2—telencephalon—epilepsy syndrome	0.000341	0.0393	CbGeAlD
Fesoterodine—CHRM1—forebrain—epilepsy syndrome	0.000338	0.0389	CbGeAlD
Fesoterodine—CHRM1—telencephalon—epilepsy syndrome	0.00031	0.0357	CbGeAlD
Fesoterodine—Tolterodine—CHRM2—epilepsy syndrome	0.00031	0.0774	CrCbGaD
Fesoterodine—Disopyramide—CHRM2—epilepsy syndrome	0.00031	0.0774	CrCbGaD
Fesoterodine—CHRM5—head—epilepsy syndrome	0.000309	0.0356	CbGeAlD
Fesoterodine—CHRM3—forebrain—epilepsy syndrome	0.000302	0.0348	CbGeAlD
Fesoterodine—CYP2D6—hindbrain—epilepsy syndrome	0.000295	0.034	CbGeAlD
Fesoterodine—CHRM5—nervous system—epilepsy syndrome	0.000293	0.0338	CbGeAlD
Fesoterodine—CHRM4—brain—epilepsy syndrome	0.000287	0.033	CbGeAlD
Fesoterodine—CHRM5—central nervous system—epilepsy syndrome	0.000282	0.0325	CbGeAlD
Fesoterodine—CHRM3—telencephalon—epilepsy syndrome	0.000278	0.032	CbGeAlD
Fesoterodine—CHRM5—brain—epilepsy syndrome	0.000224	0.0258	CbGeAlD
Fesoterodine—CHRM2—head—epilepsy syndrome	0.000212	0.0245	CbGeAlD
Fesoterodine—CHRM2—nervous system—epilepsy syndrome	0.000201	0.0232	CbGeAlD
Fesoterodine—CHRM2—central nervous system—epilepsy syndrome	0.000194	0.0223	CbGeAlD
Fesoterodine—CHRM1—head—epilepsy syndrome	0.000193	0.0223	CbGeAlD
Fesoterodine—Tolterodine—CYP2C19—epilepsy syndrome	0.000191	0.0478	CrCbGaD
Fesoterodine—CHRM1—nervous system—epilepsy syndrome	0.000183	0.0211	CbGeAlD
Fesoterodine—CHRM1—central nervous system—epilepsy syndrome	0.000176	0.0203	CbGeAlD
Fesoterodine—CHRM3—head—epilepsy syndrome	0.000173	0.0199	CbGeAlD
Fesoterodine—CYP2D6—brainstem—epilepsy syndrome	0.000169	0.0195	CbGeAlD
Fesoterodine—CHRM3—nervous system—epilepsy syndrome	0.000164	0.0189	CbGeAlD
Fesoterodine—CYP2D6—forebrain—epilepsy syndrome	0.000163	0.0188	CbGeAlD
Fesoterodine—CHRM3—central nervous system—epilepsy syndrome	0.000158	0.0182	CbGeAlD
Fesoterodine—CHRM2—brain—epilepsy syndrome	0.000154	0.0177	CbGeAlD
Fesoterodine—CYP2D6—telencephalon—epilepsy syndrome	0.00015	0.0173	CbGeAlD
Fesoterodine—Tolterodine—CYP2D6—epilepsy syndrome	0.000142	0.0354	CrCbGaD
Fesoterodine—CHRM1—brain—epilepsy syndrome	0.00014	0.0161	CbGeAlD
Fesoterodine—CHRM3—brain—epilepsy syndrome	0.000125	0.0144	CbGeAlD
Fesoterodine—ABCB1—forebrain—epilepsy syndrome	0.000118	0.0135	CbGeAlD
Fesoterodine—ABCB1—telencephalon—epilepsy syndrome	0.000108	0.0124	CbGeAlD
Fesoterodine—Urticaria—Phenytoin—epilepsy syndrome	9.91e-05	0.00072	CcSEcCtD
Fesoterodine—Cardiac disorder—Gabapentin—epilepsy syndrome	9.91e-05	0.00072	CcSEcCtD
Fesoterodine—Palpitations—Valproic Acid—epilepsy syndrome	9.9e-05	0.00072	CcSEcCtD
Fesoterodine—Pruritus—Vigabatrin—epilepsy syndrome	9.89e-05	0.000719	CcSEcCtD
Fesoterodine—Asthenia—Diazepam—epilepsy syndrome	9.87e-05	0.000717	CcSEcCtD
Fesoterodine—Urticaria—Oxcarbazepine—epilepsy syndrome	9.86e-05	0.000717	CcSEcCtD
Fesoterodine—Constipation—Lamotrigine—epilepsy syndrome	9.84e-05	0.000715	CcSEcCtD
Fesoterodine—Nausea—Acetazolamide—epilepsy syndrome	9.83e-05	0.000715	CcSEcCtD
Fesoterodine—Dizziness—Levetiracetam—epilepsy syndrome	9.82e-05	0.000714	CcSEcCtD
Fesoterodine—Feeling abnormal—Carbamazepine—epilepsy syndrome	9.81e-05	0.000713	CcSEcCtD
Fesoterodine—Abdominal pain—Oxcarbazepine—epilepsy syndrome	9.81e-05	0.000713	CcSEcCtD
Fesoterodine—Diarrhoea—Fosphenytoin—epilepsy syndrome	9.81e-05	0.000713	CcSEcCtD
Fesoterodine—Back pain—Pregabalin—epilepsy syndrome	9.8e-05	0.000712	CcSEcCtD
Fesoterodine—Cough—Valproic Acid—epilepsy syndrome	9.78e-05	0.000711	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Carbamazepine—epilepsy syndrome	9.74e-05	0.000708	CcSEcCtD
Fesoterodine—Pruritus—Diazepam—epilepsy syndrome	9.73e-05	0.000707	CcSEcCtD
Fesoterodine—Urinary tract infection—Topiramate—epilepsy syndrome	9.72e-05	0.000707	CcSEcCtD
Fesoterodine—Rash—Propofol—epilepsy syndrome	9.69e-05	0.000705	CcSEcCtD
Fesoterodine—Dermatitis—Propofol—epilepsy syndrome	9.69e-05	0.000704	CcSEcCtD
Fesoterodine—Headache—Propofol—epilepsy syndrome	9.63e-05	0.0007	CcSEcCtD
Fesoterodine—Mediastinal disorder—Gabapentin—epilepsy syndrome	9.62e-05	0.000699	CcSEcCtD
Fesoterodine—Hypersensitivity—Zonisamide—epilepsy syndrome	9.6e-05	0.000698	CcSEcCtD
Fesoterodine—Diarrhoea—Vigabatrin—epilepsy syndrome	9.56e-05	0.000695	CcSEcCtD
Fesoterodine—Asthenia—Felbamate—epilepsy syndrome	9.55e-05	0.000694	CcSEcCtD
Fesoterodine—Vision blurred—Pregabalin—epilepsy syndrome	9.55e-05	0.000694	CcSEcCtD
Fesoterodine—Chest pain—Valproic Acid—epilepsy syndrome	9.54e-05	0.000694	CcSEcCtD
Fesoterodine—Feeling abnormal—Lamotrigine—epilepsy syndrome	9.49e-05	0.000689	CcSEcCtD
Fesoterodine—Rash—Midazolam—epilepsy syndrome	9.48e-05	0.000689	CcSEcCtD
Fesoterodine—Dizziness—Fosphenytoin—epilepsy syndrome	9.48e-05	0.000689	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	9.48e-05	0.000689	CcSEcCtD
Fesoterodine—Dermatitis—Midazolam—epilepsy syndrome	9.48e-05	0.000689	CcSEcCtD
Fesoterodine—Urticaria—Carbamazepine—epilepsy syndrome	9.46e-05	0.000688	CcSEcCtD
Fesoterodine—Headache—Midazolam—epilepsy syndrome	9.42e-05	0.000685	CcSEcCtD
Fesoterodine—Pruritus—Felbamate—epilepsy syndrome	9.42e-05	0.000685	CcSEcCtD
Fesoterodine—Abdominal pain—Carbamazepine—epilepsy syndrome	9.42e-05	0.000684	CcSEcCtD
Fesoterodine—Diarrhoea—Diazepam—epilepsy syndrome	9.41e-05	0.000684	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	9.41e-05	0.000684	CcSEcCtD
Fesoterodine—Rash—Levetiracetam—epilepsy syndrome	9.37e-05	0.000681	CcSEcCtD
Fesoterodine—Dermatitis—Levetiracetam—epilepsy syndrome	9.36e-05	0.00068	CcSEcCtD
Fesoterodine—CYP2D6—head—epilepsy syndrome	9.35e-05	0.0108	CbGeAlD
Fesoterodine—Asthenia—Zonisamide—epilepsy syndrome	9.35e-05	0.00068	CcSEcCtD
Fesoterodine—Mental disorder—Gabapentin—epilepsy syndrome	9.35e-05	0.00068	CcSEcCtD
Fesoterodine—Dry mouth—Valproic Acid—epilepsy syndrome	9.33e-05	0.000678	CcSEcCtD
Fesoterodine—Headache—Levetiracetam—epilepsy syndrome	9.31e-05	0.000676	CcSEcCtD
Fesoterodine—Angioedema—Pregabalin—epilepsy syndrome	9.26e-05	0.000673	CcSEcCtD
Fesoterodine—Hypersensitivity—Clonazepam—epilepsy syndrome	9.26e-05	0.000673	CcSEcCtD
Fesoterodine—Dizziness—Vigabatrin—epilepsy syndrome	9.24e-05	0.000672	CcSEcCtD
Fesoterodine—Confusional state—Valproic Acid—epilepsy syndrome	9.22e-05	0.00067	CcSEcCtD
Fesoterodine—Pruritus—Zonisamide—epilepsy syndrome	9.22e-05	0.00067	CcSEcCtD
Fesoterodine—Hypersensitivity—Phenytoin—epilepsy syndrome	9.19e-05	0.000668	CcSEcCtD
Fesoterodine—Flatulence—Gabapentin—epilepsy syndrome	9.16e-05	0.000665	CcSEcCtD
Fesoterodine—Urticaria—Lamotrigine—epilepsy syndrome	9.14e-05	0.000665	CcSEcCtD
Fesoterodine—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	9.14e-05	0.000665	CcSEcCtD
Fesoterodine—Nausea—Propofol—epilepsy syndrome	9.13e-05	0.000664	CcSEcCtD
Fesoterodine—Diarrhoea—Felbamate—epilepsy syndrome	9.11e-05	0.000662	CcSEcCtD
Fesoterodine—Vertigo—Pregabalin—epilepsy syndrome	9.1e-05	0.000662	CcSEcCtD
Fesoterodine—Abdominal pain—Lamotrigine—epilepsy syndrome	9.1e-05	0.000661	CcSEcCtD
Fesoterodine—Dysgeusia—Gabapentin—epilepsy syndrome	9.1e-05	0.000661	CcSEcCtD
Fesoterodine—Dizziness—Diazepam—epilepsy syndrome	9.1e-05	0.000661	CcSEcCtD
Fesoterodine—Infection—Valproic Acid—epilepsy syndrome	9.09e-05	0.000661	CcSEcCtD
Fesoterodine—Rash—Fosphenytoin—epilepsy syndrome	9.04e-05	0.000657	CcSEcCtD
Fesoterodine—Dermatitis—Fosphenytoin—epilepsy syndrome	9.03e-05	0.000656	CcSEcCtD
Fesoterodine—Asthenia—Clonazepam—epilepsy syndrome	9.01e-05	0.000655	CcSEcCtD
Fesoterodine—CYP3A4—nervous system—epilepsy syndrome	9.01e-05	0.0104	CbGeAlD
Fesoterodine—Back pain—Gabapentin—epilepsy syndrome	8.99e-05	0.000653	CcSEcCtD
Fesoterodine—Headache—Fosphenytoin—epilepsy syndrome	8.98e-05	0.000653	CcSEcCtD
Fesoterodine—Nervous system disorder—Valproic Acid—epilepsy syndrome	8.97e-05	0.000652	CcSEcCtD
Fesoterodine—Palpitations—Pregabalin—epilepsy syndrome	8.95e-05	0.000651	CcSEcCtD
Fesoterodine—Asthenia—Phenytoin—epilepsy syndrome	8.95e-05	0.000651	CcSEcCtD
Fesoterodine—Nausea—Midazolam—epilepsy syndrome	8.94e-05	0.000649	CcSEcCtD
Fesoterodine—Tachycardia—Valproic Acid—epilepsy syndrome	8.93e-05	0.000649	CcSEcCtD
Fesoterodine—Diarrhoea—Zonisamide—epilepsy syndrome	8.92e-05	0.000648	CcSEcCtD
Fesoterodine—Asthenia—Oxcarbazepine—epilepsy syndrome	8.91e-05	0.000647	CcSEcCtD
Fesoterodine—Pruritus—Clonazepam—epilepsy syndrome	8.89e-05	0.000646	CcSEcCtD
Fesoterodine—Skin disorder—Valproic Acid—epilepsy syndrome	8.88e-05	0.000646	CcSEcCtD
Fesoterodine—Urinary tract disorder—Topiramate—epilepsy syndrome	8.87e-05	0.000645	CcSEcCtD
Fesoterodine—CYP2D6—nervous system—epilepsy syndrome	8.87e-05	0.0102	CbGeAlD
Fesoterodine—Oedema peripheral—Topiramate—epilepsy syndrome	8.85e-05	0.000643	CcSEcCtD
Fesoterodine—Cough—Pregabalin—epilepsy syndrome	8.84e-05	0.000643	CcSEcCtD
Fesoterodine—Pruritus—Phenytoin—epilepsy syndrome	8.83e-05	0.000642	CcSEcCtD
Fesoterodine—Nausea—Levetiracetam—epilepsy syndrome	8.82e-05	0.000641	CcSEcCtD
Fesoterodine—Rash—Vigabatrin—epilepsy syndrome	8.81e-05	0.00064	CcSEcCtD
Fesoterodine—Dizziness—Felbamate—epilepsy syndrome	8.81e-05	0.00064	CcSEcCtD
Fesoterodine—Dermatitis—Vigabatrin—epilepsy syndrome	8.8e-05	0.00064	CcSEcCtD
Fesoterodine—Urethral disorder—Topiramate—epilepsy syndrome	8.8e-05	0.00064	CcSEcCtD
Fesoterodine—Pruritus—Oxcarbazepine—epilepsy syndrome	8.78e-05	0.000638	CcSEcCtD
Fesoterodine—Hypersensitivity—Carbamazepine—epilepsy syndrome	8.78e-05	0.000638	CcSEcCtD
Fesoterodine—Vision blurred—Gabapentin—epilepsy syndrome	8.76e-05	0.000636	CcSEcCtD
Fesoterodine—Headache—Vigabatrin—epilepsy syndrome	8.75e-05	0.000636	CcSEcCtD
Fesoterodine—CYP3A4—central nervous system—epilepsy syndrome	8.68e-05	0.00999	CbGeAlD
Fesoterodine—Rash—Diazepam—epilepsy syndrome	8.67e-05	0.000631	CcSEcCtD
Fesoterodine—Dermatitis—Diazepam—epilepsy syndrome	8.67e-05	0.00063	CcSEcCtD
Fesoterodine—Chest pain—Pregabalin—epilepsy syndrome	8.63e-05	0.000627	CcSEcCtD
Fesoterodine—Dizziness—Zonisamide—epilepsy syndrome	8.62e-05	0.000626	CcSEcCtD
Fesoterodine—Headache—Diazepam—epilepsy syndrome	8.62e-05	0.000626	CcSEcCtD
Fesoterodine—Diarrhoea—Clonazepam—epilepsy syndrome	8.59e-05	0.000625	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	8.57e-05	0.000623	CcSEcCtD
Fesoterodine—Asthenia—Carbamazepine—epilepsy syndrome	8.55e-05	0.000621	CcSEcCtD
Fesoterodine—CYP2D6—central nervous system—epilepsy syndrome	8.54e-05	0.00983	CbGeAlD
Fesoterodine—Diarrhoea—Phenytoin—epilepsy syndrome	8.54e-05	0.000621	CcSEcCtD
Fesoterodine—Nausea—Fosphenytoin—epilepsy syndrome	8.52e-05	0.000619	CcSEcCtD
Fesoterodine—Diarrhoea—Oxcarbazepine—epilepsy syndrome	8.49e-05	0.000617	CcSEcCtD
Fesoterodine—Angioedema—Gabapentin—epilepsy syndrome	8.49e-05	0.000617	CcSEcCtD
Fesoterodine—ABCB1—medulla oblongata—epilepsy syndrome	8.49e-05	0.00978	CbGeAlD
Fesoterodine—Hypersensitivity—Lamotrigine—epilepsy syndrome	8.48e-05	0.000616	CcSEcCtD
Fesoterodine—Dry mouth—Pregabalin—epilepsy syndrome	8.44e-05	0.000613	CcSEcCtD
Fesoterodine—Pruritus—Carbamazepine—epilepsy syndrome	8.43e-05	0.000612	CcSEcCtD
Fesoterodine—Rash—Felbamate—epilepsy syndrome	8.4e-05	0.00061	CcSEcCtD
Fesoterodine—Eye disorder—Topiramate—epilepsy syndrome	8.39e-05	0.00061	CcSEcCtD
Fesoterodine—Dermatitis—Felbamate—epilepsy syndrome	8.39e-05	0.00061	CcSEcCtD
Fesoterodine—Vertigo—Gabapentin—epilepsy syndrome	8.35e-05	0.000607	CcSEcCtD
Fesoterodine—CYP2D6—cerebellum—epilepsy syndrome	8.34e-05	0.00961	CbGeAlD
Fesoterodine—Headache—Felbamate—epilepsy syndrome	8.34e-05	0.000606	CcSEcCtD
Fesoterodine—Confusional state—Pregabalin—epilepsy syndrome	8.34e-05	0.000606	CcSEcCtD
Fesoterodine—Cardiac disorder—Topiramate—epilepsy syndrome	8.33e-05	0.000606	CcSEcCtD
Fesoterodine—Dizziness—Clonazepam—epilepsy syndrome	8.31e-05	0.000604	CcSEcCtD
Fesoterodine—Nausea—Vigabatrin—epilepsy syndrome	8.3e-05	0.000603	CcSEcCtD
Fesoterodine—Insomnia—Valproic Acid—epilepsy syndrome	8.27e-05	0.000601	CcSEcCtD
Fesoterodine—Asthenia—Lamotrigine—epilepsy syndrome	8.26e-05	0.0006	CcSEcCtD
Fesoterodine—Dizziness—Phenytoin—epilepsy syndrome	8.25e-05	0.0006	CcSEcCtD
Fesoterodine—Rash—Zonisamide—epilepsy syndrome	8.22e-05	0.000597	CcSEcCtD
Fesoterodine—Infection—Pregabalin—epilepsy syndrome	8.22e-05	0.000597	CcSEcCtD
Fesoterodine—Palpitations—Gabapentin—epilepsy syndrome	8.21e-05	0.000597	CcSEcCtD
Fesoterodine—Dermatitis—Zonisamide—epilepsy syndrome	8.21e-05	0.000597	CcSEcCtD
Fesoterodine—Dizziness—Oxcarbazepine—epilepsy syndrome	8.21e-05	0.000597	CcSEcCtD
Fesoterodine—Nausea—Diazepam—epilepsy syndrome	8.17e-05	0.000594	CcSEcCtD
Fesoterodine—Headache—Zonisamide—epilepsy syndrome	8.17e-05	0.000594	CcSEcCtD
Fesoterodine—Diarrhoea—Carbamazepine—epilepsy syndrome	8.15e-05	0.000592	CcSEcCtD
Fesoterodine—Pruritus—Lamotrigine—epilepsy syndrome	8.14e-05	0.000592	CcSEcCtD
Fesoterodine—Somnolence—Valproic Acid—epilepsy syndrome	8.13e-05	0.000591	CcSEcCtD
Fesoterodine—Nervous system disorder—Pregabalin—epilepsy syndrome	8.11e-05	0.000589	CcSEcCtD
Fesoterodine—Cough—Gabapentin—epilepsy syndrome	8.11e-05	0.000589	CcSEcCtD
Fesoterodine—Mediastinal disorder—Topiramate—epilepsy syndrome	8.09e-05	0.000588	CcSEcCtD
Fesoterodine—Tachycardia—Pregabalin—epilepsy syndrome	8.07e-05	0.000587	CcSEcCtD
Fesoterodine—Dyspepsia—Valproic Acid—epilepsy syndrome	8.05e-05	0.000585	CcSEcCtD
Fesoterodine—Skin disorder—Pregabalin—epilepsy syndrome	8.03e-05	0.000584	CcSEcCtD
Fesoterodine—Rash—Clonazepam—epilepsy syndrome	7.92e-05	0.000576	CcSEcCtD
Fesoterodine—Dermatitis—Clonazepam—epilepsy syndrome	7.91e-05	0.000575	CcSEcCtD
Fesoterodine—Chest pain—Gabapentin—epilepsy syndrome	7.91e-05	0.000575	CcSEcCtD
Fesoterodine—Nausea—Felbamate—epilepsy syndrome	7.91e-05	0.000575	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	7.9e-05	0.000574	CcSEcCtD
Fesoterodine—Fatigue—Valproic Acid—epilepsy syndrome	7.89e-05	0.000573	CcSEcCtD
Fesoterodine—Dizziness—Carbamazepine—epilepsy syndrome	7.88e-05	0.000572	CcSEcCtD
Fesoterodine—Diarrhoea—Lamotrigine—epilepsy syndrome	7.88e-05	0.000572	CcSEcCtD
Fesoterodine—Headache—Clonazepam—epilepsy syndrome	7.87e-05	0.000572	CcSEcCtD
Fesoterodine—Rash—Phenytoin—epilepsy syndrome	7.87e-05	0.000572	CcSEcCtD
Fesoterodine—Mental disorder—Topiramate—epilepsy syndrome	7.87e-05	0.000572	CcSEcCtD
Fesoterodine—Dermatitis—Phenytoin—epilepsy syndrome	7.86e-05	0.000571	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	7.86e-05	0.000571	CcSEcCtD
Fesoterodine—Rash—Oxcarbazepine—epilepsy syndrome	7.83e-05	0.000569	CcSEcCtD
Fesoterodine—Constipation—Valproic Acid—epilepsy syndrome	7.82e-05	0.000569	CcSEcCtD
Fesoterodine—Dermatitis—Oxcarbazepine—epilepsy syndrome	7.82e-05	0.000568	CcSEcCtD
Fesoterodine—Headache—Phenytoin—epilepsy syndrome	7.82e-05	0.000568	CcSEcCtD
Fesoterodine—Headache—Oxcarbazepine—epilepsy syndrome	7.78e-05	0.000565	CcSEcCtD
Fesoterodine—ABCB1—midbrain—epilepsy syndrome	7.76e-05	0.00894	CbGeAlD
Fesoterodine—Nausea—Zonisamide—epilepsy syndrome	7.74e-05	0.000563	CcSEcCtD
Fesoterodine—Dry mouth—Gabapentin—epilepsy syndrome	7.74e-05	0.000562	CcSEcCtD
Fesoterodine—Flatulence—Topiramate—epilepsy syndrome	7.7e-05	0.00056	CcSEcCtD
Fesoterodine—Dysgeusia—Topiramate—epilepsy syndrome	7.65e-05	0.000556	CcSEcCtD
Fesoterodine—Confusional state—Gabapentin—epilepsy syndrome	7.65e-05	0.000556	CcSEcCtD
Fesoterodine—Dizziness—Lamotrigine—epilepsy syndrome	7.61e-05	0.000553	CcSEcCtD
Fesoterodine—ABCB1—spinal cord—epilepsy syndrome	7.57e-05	0.00872	CbGeAlD
Fesoterodine—Back pain—Topiramate—epilepsy syndrome	7.56e-05	0.00055	CcSEcCtD
Fesoterodine—Feeling abnormal—Valproic Acid—epilepsy syndrome	7.54e-05	0.000548	CcSEcCtD
Fesoterodine—Infection—Gabapentin—epilepsy syndrome	7.53e-05	0.000548	CcSEcCtD
Fesoterodine—Rash—Carbamazepine—epilepsy syndrome	7.51e-05	0.000546	CcSEcCtD
Fesoterodine—Dermatitis—Carbamazepine—epilepsy syndrome	7.5e-05	0.000545	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	7.48e-05	0.000544	CcSEcCtD
Fesoterodine—Insomnia—Pregabalin—epilepsy syndrome	7.48e-05	0.000544	CcSEcCtD
Fesoterodine—Nausea—Clonazepam—epilepsy syndrome	7.46e-05	0.000542	CcSEcCtD
Fesoterodine—Headache—Carbamazepine—epilepsy syndrome	7.46e-05	0.000542	CcSEcCtD
Fesoterodine—Nervous system disorder—Gabapentin—epilepsy syndrome	7.44e-05	0.000541	CcSEcCtD
Fesoterodine—Nausea—Phenytoin—epilepsy syndrome	7.41e-05	0.000539	CcSEcCtD
Fesoterodine—Tachycardia—Gabapentin—epilepsy syndrome	7.4e-05	0.000538	CcSEcCtD
Fesoterodine—Nausea—Oxcarbazepine—epilepsy syndrome	7.37e-05	0.000536	CcSEcCtD
Fesoterodine—Vision blurred—Topiramate—epilepsy syndrome	7.37e-05	0.000535	CcSEcCtD
Fesoterodine—Skin disorder—Gabapentin—epilepsy syndrome	7.37e-05	0.000535	CcSEcCtD
Fesoterodine—Somnolence—Pregabalin—epilepsy syndrome	7.35e-05	0.000534	CcSEcCtD
Fesoterodine—Urticaria—Valproic Acid—epilepsy syndrome	7.27e-05	0.000528	CcSEcCtD
Fesoterodine—Rash—Lamotrigine—epilepsy syndrome	7.26e-05	0.000528	CcSEcCtD
Fesoterodine—Dermatitis—Lamotrigine—epilepsy syndrome	7.25e-05	0.000527	CcSEcCtD
Fesoterodine—Abdominal pain—Valproic Acid—epilepsy syndrome	7.23e-05	0.000526	CcSEcCtD
Fesoterodine—Headache—Lamotrigine—epilepsy syndrome	7.21e-05	0.000524	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	7.14e-05	0.000519	CcSEcCtD
Fesoterodine—Fatigue—Pregabalin—epilepsy syndrome	7.13e-05	0.000518	CcSEcCtD
Fesoterodine—Nausea—Carbamazepine—epilepsy syndrome	7.07e-05	0.000514	CcSEcCtD
Fesoterodine—Constipation—Pregabalin—epilepsy syndrome	7.07e-05	0.000514	CcSEcCtD
Fesoterodine—Vertigo—Topiramate—epilepsy syndrome	7.02e-05	0.00051	CcSEcCtD
Fesoterodine—Palpitations—Topiramate—epilepsy syndrome	6.91e-05	0.000502	CcSEcCtD
Fesoterodine—Insomnia—Gabapentin—epilepsy syndrome	6.86e-05	0.000499	CcSEcCtD
Fesoterodine—Nausea—Lamotrigine—epilepsy syndrome	6.84e-05	0.000497	CcSEcCtD
Fesoterodine—Cough—Topiramate—epilepsy syndrome	6.82e-05	0.000496	CcSEcCtD
Fesoterodine—Feeling abnormal—Pregabalin—epilepsy syndrome	6.81e-05	0.000495	CcSEcCtD
Fesoterodine—CYP2D6—brain—epilepsy syndrome	6.78e-05	0.00781	CbGeAlD
Fesoterodine—Gastrointestinal pain—Pregabalin—epilepsy syndrome	6.76e-05	0.000492	CcSEcCtD
Fesoterodine—Somnolence—Gabapentin—epilepsy syndrome	6.74e-05	0.00049	CcSEcCtD
Fesoterodine—Hypersensitivity—Valproic Acid—epilepsy syndrome	6.74e-05	0.00049	CcSEcCtD
Fesoterodine—ABCB1—head—epilepsy syndrome	6.73e-05	0.00775	CbGeAlD
Fesoterodine—Dyspepsia—Gabapentin—epilepsy syndrome	6.67e-05	0.000485	CcSEcCtD
Fesoterodine—Chest pain—Topiramate—epilepsy syndrome	6.65e-05	0.000484	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	6.61e-05	0.00048	CcSEcCtD
Fesoterodine—Urticaria—Pregabalin—epilepsy syndrome	6.57e-05	0.000477	CcSEcCtD
Fesoterodine—Asthenia—Valproic Acid—epilepsy syndrome	6.56e-05	0.000477	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	6.55e-05	0.000476	CcSEcCtD
Fesoterodine—Fatigue—Gabapentin—epilepsy syndrome	6.54e-05	0.000475	CcSEcCtD
Fesoterodine—Abdominal pain—Pregabalin—epilepsy syndrome	6.54e-05	0.000475	CcSEcCtD
Fesoterodine—Dry mouth—Topiramate—epilepsy syndrome	6.51e-05	0.000473	CcSEcCtD
Fesoterodine—Constipation—Gabapentin—epilepsy syndrome	6.48e-05	0.000471	CcSEcCtD
Fesoterodine—Pruritus—Valproic Acid—epilepsy syndrome	6.47e-05	0.00047	CcSEcCtD
Fesoterodine—Confusional state—Topiramate—epilepsy syndrome	6.43e-05	0.000468	CcSEcCtD
Fesoterodine—ABCB1—nervous system—epilepsy syndrome	6.38e-05	0.00735	CbGeAlD
Fesoterodine—Infection—Topiramate—epilepsy syndrome	6.34e-05	0.000461	CcSEcCtD
Fesoterodine—Diarrhoea—Valproic Acid—epilepsy syndrome	6.26e-05	0.000455	CcSEcCtD
Fesoterodine—Nervous system disorder—Topiramate—epilepsy syndrome	6.26e-05	0.000455	CcSEcCtD
Fesoterodine—Feeling abnormal—Gabapentin—epilepsy syndrome	6.25e-05	0.000454	CcSEcCtD
Fesoterodine—Tachycardia—Topiramate—epilepsy syndrome	6.23e-05	0.000453	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Gabapentin—epilepsy syndrome	6.2e-05	0.000451	CcSEcCtD
Fesoterodine—Skin disorder—Topiramate—epilepsy syndrome	6.2e-05	0.00045	CcSEcCtD
Fesoterodine—ABCB1—central nervous system—epilepsy syndrome	6.14e-05	0.00707	CbGeAlD
Fesoterodine—Hypersensitivity—Pregabalin—epilepsy syndrome	6.09e-05	0.000443	CcSEcCtD
Fesoterodine—Dizziness—Valproic Acid—epilepsy syndrome	6.05e-05	0.00044	CcSEcCtD
Fesoterodine—Urticaria—Gabapentin—epilepsy syndrome	6.02e-05	0.000438	CcSEcCtD
Fesoterodine—ABCB1—cerebellum—epilepsy syndrome	6e-05	0.00691	CbGeAlD
Fesoterodine—Abdominal pain—Gabapentin—epilepsy syndrome	5.99e-05	0.000436	CcSEcCtD
Fesoterodine—Asthenia—Pregabalin—epilepsy syndrome	5.93e-05	0.000431	CcSEcCtD
Fesoterodine—Pruritus—Pregabalin—epilepsy syndrome	5.85e-05	0.000425	CcSEcCtD
Fesoterodine—Insomnia—Topiramate—epilepsy syndrome	5.77e-05	0.000419	CcSEcCtD
Fesoterodine—Rash—Valproic Acid—epilepsy syndrome	5.77e-05	0.000419	CcSEcCtD
Fesoterodine—Dermatitis—Valproic Acid—epilepsy syndrome	5.76e-05	0.000419	CcSEcCtD
Fesoterodine—Headache—Valproic Acid—epilepsy syndrome	5.73e-05	0.000417	CcSEcCtD
Fesoterodine—Somnolence—Topiramate—epilepsy syndrome	5.67e-05	0.000412	CcSEcCtD
Fesoterodine—Diarrhoea—Pregabalin—epilepsy syndrome	5.66e-05	0.000411	CcSEcCtD
Fesoterodine—Dyspepsia—Topiramate—epilepsy syndrome	5.62e-05	0.000408	CcSEcCtD
Fesoterodine—Hypersensitivity—Gabapentin—epilepsy syndrome	5.59e-05	0.000406	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Topiramate—epilepsy syndrome	5.51e-05	0.0004	CcSEcCtD
Fesoterodine—Fatigue—Topiramate—epilepsy syndrome	5.5e-05	0.0004	CcSEcCtD
Fesoterodine—Dizziness—Pregabalin—epilepsy syndrome	5.47e-05	0.000397	CcSEcCtD
Fesoterodine—Constipation—Topiramate—epilepsy syndrome	5.46e-05	0.000397	CcSEcCtD
Fesoterodine—Asthenia—Gabapentin—epilepsy syndrome	5.44e-05	0.000395	CcSEcCtD
Fesoterodine—Nausea—Valproic Acid—epilepsy syndrome	5.43e-05	0.000395	CcSEcCtD
Fesoterodine—Pruritus—Gabapentin—epilepsy syndrome	5.36e-05	0.00039	CcSEcCtD
Fesoterodine—Feeling abnormal—Topiramate—epilepsy syndrome	5.26e-05	0.000382	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Topiramate—epilepsy syndrome	5.22e-05	0.000379	CcSEcCtD
Fesoterodine—Rash—Pregabalin—epilepsy syndrome	5.21e-05	0.000379	CcSEcCtD
Fesoterodine—Dermatitis—Pregabalin—epilepsy syndrome	5.21e-05	0.000379	CcSEcCtD
Fesoterodine—Diarrhoea—Gabapentin—epilepsy syndrome	5.19e-05	0.000377	CcSEcCtD
Fesoterodine—Headache—Pregabalin—epilepsy syndrome	5.18e-05	0.000377	CcSEcCtD
Fesoterodine—Urticaria—Topiramate—epilepsy syndrome	5.07e-05	0.000368	CcSEcCtD
Fesoterodine—Abdominal pain—Topiramate—epilepsy syndrome	5.04e-05	0.000367	CcSEcCtD
Fesoterodine—Dizziness—Gabapentin—epilepsy syndrome	5.01e-05	0.000364	CcSEcCtD
Fesoterodine—Nausea—Pregabalin—epilepsy syndrome	4.91e-05	0.000357	CcSEcCtD
Fesoterodine—ABCB1—brain—epilepsy syndrome	4.88e-05	0.00562	CbGeAlD
Fesoterodine—Rash—Gabapentin—epilepsy syndrome	4.78e-05	0.000348	CcSEcCtD
Fesoterodine—Dermatitis—Gabapentin—epilepsy syndrome	4.78e-05	0.000347	CcSEcCtD
Fesoterodine—Headache—Gabapentin—epilepsy syndrome	4.75e-05	0.000345	CcSEcCtD
Fesoterodine—Hypersensitivity—Topiramate—epilepsy syndrome	4.7e-05	0.000342	CcSEcCtD
Fesoterodine—Asthenia—Topiramate—epilepsy syndrome	4.58e-05	0.000333	CcSEcCtD
Fesoterodine—Pruritus—Topiramate—epilepsy syndrome	4.51e-05	0.000328	CcSEcCtD
Fesoterodine—Nausea—Gabapentin—epilepsy syndrome	4.5e-05	0.000327	CcSEcCtD
Fesoterodine—Diarrhoea—Topiramate—epilepsy syndrome	4.36e-05	0.000317	CcSEcCtD
Fesoterodine—Dizziness—Topiramate—epilepsy syndrome	4.22e-05	0.000307	CcSEcCtD
Fesoterodine—Rash—Topiramate—epilepsy syndrome	4.02e-05	0.000292	CcSEcCtD
Fesoterodine—Dermatitis—Topiramate—epilepsy syndrome	4.02e-05	0.000292	CcSEcCtD
Fesoterodine—Headache—Topiramate—epilepsy syndrome	4e-05	0.00029	CcSEcCtD
Fesoterodine—Nausea—Topiramate—epilepsy syndrome	3.79e-05	0.000275	CcSEcCtD
Fesoterodine—CHRM1—Signaling by GPCR—PRKCB—epilepsy syndrome	4.74e-06	5.85e-05	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—POMC—epilepsy syndrome	4.74e-06	5.85e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—HTR2A—epilepsy syndrome	4.73e-06	5.85e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—PRKCB—epilepsy syndrome	4.72e-06	5.83e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—IL6ST—epilepsy syndrome	4.72e-06	5.83e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—NT5E—epilepsy syndrome	4.71e-06	5.82e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—ALAD—epilepsy syndrome	4.71e-06	5.82e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—IL6ST—epilepsy syndrome	4.7e-06	5.81e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CXCL12—epilepsy syndrome	4.7e-06	5.8e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—BDKRB2—epilepsy syndrome	4.7e-06	5.8e-05	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—POMC—epilepsy syndrome	4.69e-06	5.8e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—PRKCB—epilepsy syndrome	4.68e-06	5.78e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—JUNB—epilepsy syndrome	4.67e-06	5.77e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CNR1—epilepsy syndrome	4.67e-06	5.77e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—IL6ST—epilepsy syndrome	4.66e-06	5.75e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—JUNB—epilepsy syndrome	4.66e-06	5.75e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CNR1—epilepsy syndrome	4.66e-06	5.75e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—PLCB1—epilepsy syndrome	4.65e-06	5.75e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—PLCB1—epilepsy syndrome	4.64e-06	5.73e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—CCR5—epilepsy syndrome	4.63e-06	5.72e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—HMOX1—epilepsy syndrome	4.61e-06	5.7e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—JUNB—epilepsy syndrome	4.61e-06	5.7e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CNR1—epilepsy syndrome	4.61e-06	5.7e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—PLCB1—epilepsy syndrome	4.59e-06	5.68e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—HTR7—epilepsy syndrome	4.56e-06	5.63e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—CAT—epilepsy syndrome	4.55e-06	5.62e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—HTR7—epilepsy syndrome	4.54e-06	5.61e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—HTR2A—epilepsy syndrome	4.53e-06	5.6e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—ABCG2—epilepsy syndrome	4.5e-06	5.56e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—HTR7—epilepsy syndrome	4.5e-06	5.56e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—TSC2—epilepsy syndrome	4.5e-06	5.56e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—AGT—epilepsy syndrome	4.49e-06	5.55e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	4.49e-06	5.55e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	4.49e-06	5.55e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—ABCB1—epilepsy syndrome	4.43e-06	5.47e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—HBEGF—epilepsy syndrome	4.42e-06	5.47e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—HBEGF—epilepsy syndrome	4.41e-06	5.45e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—APOE—epilepsy syndrome	4.4e-06	5.44e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	4.39e-06	5.43e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	4.39e-06	5.42e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—HBEGF—epilepsy syndrome	4.37e-06	5.4e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	4.36e-06	5.39e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—AKT3—epilepsy syndrome	4.34e-06	5.36e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—AKT3—epilepsy syndrome	4.33e-06	5.35e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—POMC—epilepsy syndrome	4.31e-06	5.33e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—KDR—epilepsy syndrome	4.31e-06	5.33e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—TSC2—epilepsy syndrome	4.31e-06	5.32e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—ADSL—epilepsy syndrome	4.3e-06	5.32e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—POMC—epilepsy syndrome	4.3e-06	5.31e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—AGT—epilepsy syndrome	4.3e-06	5.31e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—AKT3—epilepsy syndrome	4.29e-06	5.3e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—POMC—epilepsy syndrome	4.26e-06	5.26e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	4.24e-06	5.24e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—ADAM10—epilepsy syndrome	4.24e-06	5.24e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—ADAM10—epilepsy syndrome	4.23e-06	5.22e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—CCL2—epilepsy syndrome	4.22e-06	5.22e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—GLUL—epilepsy syndrome	4.22e-06	5.22e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—APOE—epilepsy syndrome	4.21e-06	5.21e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—CCL2—epilepsy syndrome	4.21e-06	5.2e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—ADAM10—epilepsy syndrome	4.19e-06	5.17e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—CCL2—epilepsy syndrome	4.17e-06	5.15e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	4.16e-06	5.14e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—PRKCB—epilepsy syndrome	4.15e-06	5.13e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	4.14e-06	5.12e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	4.13e-06	5.11e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—IL6ST—epilepsy syndrome	4.13e-06	5.11e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—KDR—epilepsy syndrome	4.13e-06	5.1e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—GPX1—epilepsy syndrome	4.12e-06	5.09e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	4.11e-06	5.08e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—S100B—epilepsy syndrome	4.01e-06	4.96e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—S100B—epilepsy syndrome	4e-06	4.94e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—PRKCB—epilepsy syndrome	3.97e-06	4.91e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—SOCS3—epilepsy syndrome	3.97e-06	4.91e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CDC42—epilepsy syndrome	3.96e-06	4.9e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—S100B—epilepsy syndrome	3.96e-06	4.89e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—SOCS3—epilepsy syndrome	3.96e-06	4.89e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—IL6ST—epilepsy syndrome	3.96e-06	4.89e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CDC42—epilepsy syndrome	3.95e-06	4.88e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	3.94e-06	4.86e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—SOCS3—epilepsy syndrome	3.92e-06	4.84e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CDC42—epilepsy syndrome	3.91e-06	4.83e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	3.88e-06	4.79e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—AVP—epilepsy syndrome	3.84e-06	4.74e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—AVP—epilepsy syndrome	3.82e-06	4.72e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—AVP—epilepsy syndrome	3.79e-06	4.68e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—POMC—epilepsy syndrome	3.78e-06	4.67e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—AQP1—epilepsy syndrome	3.76e-06	4.65e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	3.75e-06	4.64e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	3.75e-06	4.63e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—BCHE—epilepsy syndrome	3.73e-06	4.61e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—CCL2—epilepsy syndrome	3.7e-06	4.57e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—HES1—epilepsy syndrome	3.63e-06	4.48e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—POMC—epilepsy syndrome	3.62e-06	4.47e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—HES1—epilepsy syndrome	3.62e-06	4.47e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—AGT—epilepsy syndrome	3.61e-06	4.46e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—HES1—epilepsy syndrome	3.58e-06	4.42e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	3.56e-06	4.4e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—CCL2—epilepsy syndrome	3.54e-06	4.38e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—APOE—epilepsy syndrome	3.54e-06	4.37e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	3.53e-06	4.36e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—FYN—epilepsy syndrome	3.53e-06	4.36e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—PLCB1—epilepsy syndrome	3.52e-06	4.35e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—FYN—epilepsy syndrome	3.52e-06	4.34e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—BCHE—epilepsy syndrome	3.52e-06	4.34e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—H2AFX—epilepsy syndrome	3.51e-06	4.34e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—MEF2C—epilepsy syndrome	3.51e-06	4.33e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—TH—epilepsy syndrome	3.51e-06	4.33e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—H2AFX—epilepsy syndrome	3.5e-06	4.33e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—MEF2C—epilepsy syndrome	3.5e-06	4.32e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—FYN—epilepsy syndrome	3.48e-06	4.3e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—H2AFX—epilepsy syndrome	3.47e-06	4.29e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—MEF2C—epilepsy syndrome	3.46e-06	4.28e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	3.4e-06	4.2e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	3.4e-06	4.2e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—YWHAZ—epilepsy syndrome	3.39e-06	4.19e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—YWHAZ—epilepsy syndrome	3.38e-06	4.18e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	3.35e-06	4.14e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—NGF—epilepsy syndrome	3.35e-06	4.14e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—YWHAZ—epilepsy syndrome	3.35e-06	4.14e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—FGF2—epilepsy syndrome	3.34e-06	4.13e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—NGF—epilepsy syndrome	3.34e-06	4.13e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	3.32e-06	4.1e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—NGF—epilepsy syndrome	3.31e-06	4.09e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—TH—epilepsy syndrome	3.31e-06	4.08e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CCR5—epilepsy syndrome	3.26e-06	4.03e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CCR5—epilepsy syndrome	3.25e-06	4.02e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CCR5—epilepsy syndrome	3.22e-06	3.98e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—FGF2—epilepsy syndrome	3.2e-06	3.96e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—HTR2A—epilepsy syndrome	3.19e-06	3.94e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—HTR2A—epilepsy syndrome	3.18e-06	3.93e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—HTR2A—epilepsy syndrome	3.15e-06	3.89e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—RELA—epilepsy syndrome	3.1e-06	3.83e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—MTOR—epilepsy syndrome	3.04e-06	3.76e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—POMC—epilepsy syndrome	3.04e-06	3.75e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—TSC2—epilepsy syndrome	3.03e-06	3.75e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—AGT—epilepsy syndrome	3.03e-06	3.74e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—TSC2—epilepsy syndrome	3.02e-06	3.73e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—AGT—epilepsy syndrome	3.02e-06	3.73e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—TSC2—epilepsy syndrome	2.99e-06	3.7e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—AGT—epilepsy syndrome	2.99e-06	3.69e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—RELA—epilepsy syndrome	2.97e-06	3.67e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—APOE—epilepsy syndrome	2.97e-06	3.67e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—APOE—epilepsy syndrome	2.96e-06	3.65e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—APOE—epilepsy syndrome	2.93e-06	3.62e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—HMOX1—epilepsy syndrome	2.93e-06	3.62e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—MTOR—epilepsy syndrome	2.91e-06	3.6e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—KDR—epilepsy syndrome	2.91e-06	3.59e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—KDR—epilepsy syndrome	2.9e-06	3.58e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—CAT—epilepsy syndrome	2.89e-06	3.57e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—KDR—epilepsy syndrome	2.87e-06	3.55e-05	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR downstream signaling—AKT1—epilepsy syndrome	2.82e-06	3.49e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—CASP3—epilepsy syndrome	2.8e-06	3.46e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—PRKCB—epilepsy syndrome	2.8e-06	3.46e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—PRKCB—epilepsy syndrome	2.79e-06	3.45e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—IL6ST—epilepsy syndrome	2.79e-06	3.44e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—IL6ST—epilepsy syndrome	2.78e-06	3.43e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	2.77e-06	3.43e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—ALB—epilepsy syndrome	2.77e-06	3.42e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—PRKCB—epilepsy syndrome	2.76e-06	3.41e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	2.76e-06	3.41e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—IL6ST—epilepsy syndrome	2.75e-06	3.4e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—CAT—epilepsy syndrome	2.72e-06	3.36e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—JUN—epilepsy syndrome	2.72e-06	3.36e-05	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR downstream signaling—AKT1—epilepsy syndrome	2.71e-06	3.34e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	2.7e-06	3.34e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	2.69e-06	3.32e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—CASP3—epilepsy syndrome	2.68e-06	3.31e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	2.65e-06	3.27e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—MMP9—epilepsy syndrome	2.64e-06	3.27e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—GPX1—epilepsy syndrome	2.61e-06	3.23e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—JUN—epilepsy syndrome	2.6e-06	3.22e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—AKT1—epilepsy syndrome	2.57e-06	3.17e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—POMC—epilepsy syndrome	2.55e-06	3.15e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—POMC—epilepsy syndrome	2.54e-06	3.14e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—MMP9—epilepsy syndrome	2.53e-06	3.13e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—POMC—epilepsy syndrome	2.52e-06	3.11e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CCL2—epilepsy syndrome	2.49e-06	3.08e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CCL2—epilepsy syndrome	2.49e-06	3.07e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CCL2—epilepsy syndrome	2.46e-06	3.04e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—GPX1—epilepsy syndrome	2.46e-06	3.04e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—AKT1—epilepsy syndrome	2.46e-06	3.04e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—SRC—epilepsy syndrome	2.44e-06	3.01e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	2.42e-06	3e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—PTGS2—epilepsy syndrome	2.42e-06	2.99e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—VEGFA—epilepsy syndrome	2.38e-06	2.93e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—SRC—epilepsy syndrome	2.34e-06	2.89e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	2.31e-06	2.85e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—BCHE—epilepsy syndrome	2.3e-06	2.84e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—AGT—epilepsy syndrome	2.29e-06	2.83e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—VEGFA—epilepsy syndrome	2.27e-06	2.81e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—FGF2—epilepsy syndrome	2.25e-06	2.78e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—FGF2—epilepsy syndrome	2.25e-06	2.78e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—APOE—epilepsy syndrome	2.24e-06	2.77e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—FGF2—epilepsy syndrome	2.22e-06	2.75e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	2.19e-06	2.71e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	2.17e-06	2.68e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—TH—epilepsy syndrome	2.16e-06	2.67e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—AGT—epilepsy syndrome	2.16e-06	2.67e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—APOE—epilepsy syndrome	2.11e-06	2.61e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—RELA—epilepsy syndrome	2.09e-06	2.59e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—RELA—epilepsy syndrome	2.09e-06	2.58e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—RELA—epilepsy syndrome	2.07e-06	2.55e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—MTOR—epilepsy syndrome	2.05e-06	2.54e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—MTOR—epilepsy syndrome	2.05e-06	2.53e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—MTOR—epilepsy syndrome	2.03e-06	2.5e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—POMC—epilepsy syndrome	1.93e-06	2.38e-05	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—AKT1—epilepsy syndrome	1.9e-06	2.35e-05	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—AKT1—epilepsy syndrome	1.9e-06	2.35e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CASP3—epilepsy syndrome	1.89e-06	2.33e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CASP3—epilepsy syndrome	1.88e-06	2.32e-05	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—AKT1—epilepsy syndrome	1.88e-06	2.32e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CASP3—epilepsy syndrome	1.86e-06	2.3e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—JUN—epilepsy syndrome	1.83e-06	2.26e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—JUN—epilepsy syndrome	1.83e-06	2.26e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—POMC—epilepsy syndrome	1.82e-06	2.24e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—JUN—epilepsy syndrome	1.81e-06	2.24e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.8e-06	2.23e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—MMP9—epilepsy syndrome	1.78e-06	2.2e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.78e-06	2.2e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—MMP9—epilepsy syndrome	1.78e-06	2.2e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—MMP9—epilepsy syndrome	1.76e-06	2.18e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—ALB—epilepsy syndrome	1.76e-06	2.17e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.73e-06	2.14e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—AKT1—epilepsy syndrome	1.73e-06	2.14e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—AKT1—epilepsy syndrome	1.72e-06	2.13e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—AKT1—epilepsy syndrome	1.71e-06	2.11e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—ALB—epilepsy syndrome	1.66e-06	2.05e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—SRC—epilepsy syndrome	1.64e-06	2.03e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—SRC—epilepsy syndrome	1.64e-06	2.03e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—SRC—epilepsy syndrome	1.62e-06	2.01e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1.61e-06	1.99e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—VEGFA—epilepsy syndrome	1.6e-06	1.98e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—VEGFA—epilepsy syndrome	1.6e-06	1.97e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—VEGFA—epilepsy syndrome	1.58e-06	1.95e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—PTGS2—epilepsy syndrome	1.54e-06	1.9e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—AKT1—epilepsy syndrome	1.52e-06	1.87e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—AKT1—epilepsy syndrome	1.45e-06	1.79e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	1.45e-06	1.79e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.41e-06	1.74e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—APOE—epilepsy syndrome	1.38e-06	1.71e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—AKT1—epilepsy syndrome	1.22e-06	1.51e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.19e-06	1.47e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.08e-06	1.34e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—AKT1—epilepsy syndrome	1.02e-06	1.26e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—AKT1—epilepsy syndrome	1.02e-06	1.26e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—AKT1—epilepsy syndrome	1.01e-06	1.25e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	9.47e-07	1.17e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—AKT1—epilepsy syndrome	7.73e-07	9.55e-06	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—AKT1—epilepsy syndrome	7.28e-07	9e-06	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—AKT1—epilepsy syndrome	4.76e-07	5.88e-06	CbGpPWpGaD
